Results 71 to 80 of about 13,584 (291)

Nocebo effects in visceral pain: concept and design of the experimental randomized-controlled pain study ‘NoVis’

open access: yesFrontiers in Psychiatry, 2023
The role of psychological factors in the pathophysiology and treatment of chronic visceral pain in disorders of gut-brain interactions (DGBI) is increasingly appreciated.
J. L. Aulenkamp   +2 more
semanticscholar   +1 more source

Role of conditioning and verbal suggestion in placebo and nocebo effects on itch. [PDF]

open access: yesPLoS ONE, 2014
Placebo and nocebo effects are known to play a key role in treatment effects in a wide variety of conditions. These effects have frequently been investigated with regard to pain and also in other physical sensations, but have hardly been investigated ...
Danielle J P Bartels   +7 more
doaj   +1 more source

How to prevent, minimize, or extinguish nocebo effects in pain: a narrative review on mechanisms, predictors, and interventions

open access: yesPAIN Reports, 2019
. Nocebo effects, such as side effects due to negative expectations regarding the pain treatment, are a concern for health care providers and come with significant costs.
Meriem Manaï   +4 more
doaj   +1 more source

What Physiotherapists Specialized in Orthopedic Manual Therapy Know About Nocebo-Related Effects and Contextual Factors: Findings From a National Survey

open access: yesFrontiers in Psychology, 2020
ObjectiveThe aim of this study was to investigate the knowledge of orthopedic manual therapists (OMTs) regarding context factors (CFs) capable of triggering nocebo effects during the treatment and how this knowledge is related to their socio-demographic ...
Giacomo Rossettini   +11 more
doaj   +1 more source

Susceptibility to Nocebo Hyperalgesia, Dispositional Optimism, and Trait Anxiety as Predictors of Nocebo Hyperalgesia Reduction

open access: yesThe Clinical Journal of Pain, 2023
Objectives: The current paper explores the psychological predictors of nocebo hyperalgesia and whether the reduction of nocebo hyperalgesia can be predicted by susceptibility to nocebo hyperalgesia and psychological characteristics.
Merve Karacaoglu   +7 more
semanticscholar   +1 more source

Regulation with Placebo Effects [PDF]

open access: yes, 2008
A growing scientific literature supports the existence of placebo effects from a wide range of health interventions and for a range of medical conditions.
Malani, Anup
core   +1 more source

Exposing the evidence gap for complementary and alternative medicine to be integrated into science-based medicine. [PDF]

open access: yes, 2011
When people who advocate integrating conventional science-based medicine with complementary and alternative medicine (CAM) are confronted with the lack of evidence to support CAM they counter by calling for more research, diverting attention to the ...
Hopayian, K, Power, M.
core   +1 more source

Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta‐Analysis

open access: yesMovement Disorders
Clinical trials of new drugs for tic disorders (TD) often fail to yield positive results. Placebo and nocebo responses play a vital role in interpreting the outcomes of randomized controlled trials (RCTs), yet these responses in RCTs of TD remain ...
Simeng Wang   +9 more
semanticscholar   +1 more source

Nocebo response in dentistry: A systematic review and meta-analysis of adverse events in analgesic trials of third molar removal.

open access: yesJournal of Oral Rehabilitation, 2023
BACKGROUND The nocebo response refers to the phenomenon where nonspecific factors, including negative verbal suggestion and treatment expectations, cause adverse events (AE) following a placebo treatment.
Takeshi Watanabe   +7 more
semanticscholar   +1 more source

A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy